Test of CD47-SIRPα Inhibitors on the Immune Microenvironment Colon Cancer

计划入组 115 人 · 首次发布于 2023 年 7 月 21 日

Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer

计划入组 27 人 · 首次发布于 2020 年 5 月 28 日

First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228

计划入组 17 人 · 首次发布于 2023 年 2 月 21 日

anti-SIRPγ fusion protein (Jiangsu hengrui)

anti-PDL1/SIRPγ bifunctional fusion protein (Jiangsu hengrui)

SIRPα-PDL1

Electra Therapeutics Launches Phase 1 Trial of ELA822, a SIRPγ-Specific Antibody for Chronic T Cell-Mediated Diseases

Biosion Initiates Phase 1 Trial of BSI-082 Anti-SIRPα Antibody for Advanced Solid Tumors

Electra's ELA026 Shows Promise in Treating Life-Threatening sHLH